Observational, prospective, phase 4 study in patients with first‐line recurrent and/or metastatic squamous cell carcinoma of the head and neck treated with cetuximab …
J Guigay, E Chamorey, G Lefebvre, M Rotarski… - Cancer …, 2022 - Wiley Online Library
Background Cetuximab plus platinum‐based therapy (PBT) followed by cetuximab
maintenance until progression (EXTREME) is a guideline‐recommended first‐line treatment …
maintenance until progression (EXTREME) is a guideline‐recommended first‐line treatment …
[HTML][HTML] Observational, prospective, phase 4 study in patients with first‐line recurrent and/or metastatic squamous cell carcinoma of the head and neck treated with …
J Guigay, E Chamorey, G Lefebvre, M Rotarski… - Cancer …, 2022 - ncbi.nlm.nih.gov
Background Cetuximab plus platinum‐based therapy (PBT) followed by cetuximab
maintenance until progression (EXTREME) is a guideline‐recommended first‐line treatment …
maintenance until progression (EXTREME) is a guideline‐recommended first‐line treatment …
[PDF][PDF] Observational, prospective, phase 4 study in patients with first-line recurrent and/or metastatic squamous cell carcinoma of the head and neck treated with …
J Guigay, E Chamorey, G Lefebvre, M Rotarski… - 2021 - scholar.archive.org
Background: Cetuximab plus platinum-based therapy (PBT) followed by cetuximab
maintenance until progression (EXTREME) is a guideline-recommended first-line treatment …
maintenance until progression (EXTREME) is a guideline-recommended first-line treatment …
Observational, prospective, phase 4 study in patients with first-line recurrent and/or metastatic squamous cell carcinoma of the head and neck treated with cetuximab …
J Guigay, E Chamorey, G Lefebvre… - Cancer Reports …, 2021 - europepmc.org
Background Cetuximab plus platinum-based therapy (PBT) followed by cetuximab
maintenance until progression (EXTREME) is a guideline-recommended first-line treatment …
maintenance until progression (EXTREME) is a guideline-recommended first-line treatment …
Observational, prospective, phase 4 study in patients with first-line recurrent and/or metastatic squamous cell carcinoma of the head and neck treated with cetuximab …
J Guigay, E Chamorey, G Lefebvre… - Cancer reports …, 2022 - pubmed.ncbi.nlm.nih.gov
Background Cetuximab plus platinum-based therapy (PBT) followed by cetuximab
maintenance until progression (EXTREME) is a guideline-recommended first-line treatment …
maintenance until progression (EXTREME) is a guideline-recommended first-line treatment …
[PDF][PDF] Observational, prospective, phase 4 study in patients with first-line recurrent and/or metastatic squamous cell carcinoma of the head and neck treated with …
J Guigay, E Chamorey, G Lefebvre, M Rotarski… - 2021 - researchgate.net
Background: Cetuximab plus platinum-based therapy (PBT) followed by cetuximab
maintenance until progression (EXTREME) is a guideline-recommended first-line treatment …
maintenance until progression (EXTREME) is a guideline-recommended first-line treatment …